This on-demand preparation model allows PlexusDx to serve patients in rural areas, underserved communities, and states where Ozempic distribution remains limited or delayed
Syn-Ake Syn-Ake is a synthetic peptide designed to mimic Waglerin-1 functionality
It was found that the expression of GCH1 triggers the production of potent antioxidants BH4/BH2, which can block lipid peroxidation and ferroptosis, whether supplemented exogenously or produced endogenously
However, at a 12.6 gram scoop weight, it's nearly twice the size of the previous formula (and fully disclosed), adding a lot more value - especially since there's now a 200 milligram caffeine dose, and no need to double-scoop it for more energy
Here's what you need to know: Medicare Coverage (Effective Mid-2026) Following the November 2025 Trump administration agreements, Medicare will cover GLP-1 medications for obesity with: $50 monthly copay for eligible patients $245 government cost (down from $1,000+ list prices) Medicare Eligibility Requirements: BMI over 27 with prediabetes OR established cardiovascular disease, OR BMI over 30 with uncontrolled hypertension, kidney disease, or heart failure, OR BMI over 35 (severe obesity) Medicaid Coverage States can opt into $245 monthly pricing for all covered uses
2024 PMID: 39226030
